ZA975858B - Melanoma associated peptide analogues and vaccines against melanoma - Google Patents

Melanoma associated peptide analogues and vaccines against melanoma

Info

Publication number
ZA975858B
ZA975858B ZA975858A ZA975858A ZA975858B ZA 975858 B ZA975858 B ZA 975858B ZA 975858 A ZA975858 A ZA 975858A ZA 975858 A ZA975858 A ZA 975858A ZA 975858 B ZA975858 B ZA 975858B
Authority
ZA
South Africa
Prior art keywords
melanoma
peptide analogues
associated peptide
vaccines against
ctl
Prior art date
Application number
ZA975858A
Other languages
English (en)
Inventor
Carl Gustav Figdor
Gosse Jan Adema
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA975858B publication Critical patent/ZA975858B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA975858A 1996-07-11 1997-07-01 Melanoma associated peptide analogues and vaccines against melanoma ZA975858B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201945 1996-07-11

Publications (1)

Publication Number Publication Date
ZA975858B true ZA975858B (en) 1998-09-01

Family

ID=8224171

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975858A ZA975858B (en) 1996-07-11 1997-07-01 Melanoma associated peptide analogues and vaccines against melanoma

Country Status (10)

Country Link
EP (1) EP0934405B1 (de)
JP (2) JP4386463B2 (de)
AT (1) ATE206759T1 (de)
AU (1) AU3693897A (de)
CA (1) CA2259944C (de)
DE (1) DE69707296T2 (de)
ES (1) ES2165619T3 (de)
ID (1) ID18726A (de)
WO (1) WO1998002538A1 (de)
ZA (1) ZA975858B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
FR2763071B1 (fr) * 1997-05-07 2003-05-16 Centre Nat Rech Scient Analogues peptidiques, et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic
CA2295321C (en) * 1997-06-23 2008-01-29 Ludwig Institute For Cancer Research Isolated nona- and decapeptides which bind to hla molecules, and the use thereof
AU1013601A (en) 1999-10-22 2001-05-08 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
CA2438505A1 (en) * 2001-02-14 2002-09-12 Genzyme Corporation Altered peptide ligands
CA2674445C (en) 2007-01-12 2016-06-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Gp100-specific t cell receptors and related materials and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE272113T1 (de) * 1994-02-16 2004-08-15 Crucell Holland Bv Melanoma-assoziierte antigene, epitope davon und impstoffe gegen melanoma
EP0756604A1 (de) * 1994-04-22 1997-02-05 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Melanoma antigene
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma

Also Published As

Publication number Publication date
ATE206759T1 (de) 2001-10-15
JP4386463B2 (ja) 2009-12-16
JP2000515739A (ja) 2000-11-28
ID18726A (id) 1998-05-07
CA2259944C (en) 2011-06-28
CA2259944A1 (en) 1998-01-22
ES2165619T3 (es) 2002-03-16
DE69707296T2 (de) 2002-07-25
WO1998002538A1 (en) 1998-01-22
EP0934405A1 (de) 1999-08-11
JP2009178166A (ja) 2009-08-13
AU3693897A (en) 1998-02-09
EP0934405B1 (de) 2001-10-10
JP5198354B2 (ja) 2013-05-15
DE69707296D1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
AU1227295A (en) Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
WO2006014579A3 (en) Enhancing class i antigen presentation with synthetic sequences
WO1995029193A3 (en) Melanoma antigens
NZ232554A (en) 100,000 dalton tumour cell glycoprotein antigen (l45), monoclonal antibodies thereto and medicaments
CY1107706T1 (el) Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea)
GB8703700D0 (en) Monoclonal antibodies
HK1093314A1 (en) Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
ZA975858B (en) Melanoma associated peptide analogues and vaccines against melanoma
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
ATE344052T1 (de) Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
AU2003241127A8 (en) Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes
NZ213303A (en) Plasmodium protein, dna sequence and vaccine
NZ515332A (en) Lawsonia derived gene and related SodC polypeptides, peptides and proteins and their uses
ES2012815A6 (es) Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma, y para preparar vacunas que los contienen.
EP1502602A3 (de) Verfahren zur therapeutischen Impfung
EP0320034A3 (de) Synthetische Peptide, die immunologische Aktivität zeigen, benutzbar, um eine Impfung gegen Malaria vorzubereiten
Kolesanova et al. B-Cell Linear Epitopes in the Conservative Regions of Hepatitis C Virus Envelope Glycoproteins
Sarobe Peptidos sinteticos en la induccion de la respuesta inmune humoral: Obtencion de anticuerpos neutralizantes frente al VIH-1.
Gulley et al. Analysis of PSA-Specific T-Cell Responses of Prostate Cancer Patients Given a PSA-Based Vaccine on a Clinical Trial
RU92004487A (ru) Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов